FDA Inspection 1192551 — Neutraderm, Inc.

Neutraderm, Inc. — FEI 3006402197

The FDA completed an inspection of Neutraderm, Inc. on Dec 9, 2022 in Chatsworth, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 9, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chatsworth, CA (United States)

Citations

IDCFRDescription
109821 CFR 211.22(c)Approve or reject procedures or specs
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
122021 CFR 211.67(b)(3)Cleaning SOPs/instructions
144821 CFR 211.111Establishment of time limitations
197521 CFR 211.182Written records kept in individual logs
361421 CFR 211.160(b)(4)Written calibration procedures